Agmatinase, putative

BE0003044ProteinDeinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)

Agmatinase, putative (Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)) is a protein target in DrugBank. It is acted on by 1 drug in DrugBank.

UniProtKB entry: Q9RZ04TrEMBL
Residues / weight: 304 residues · 32,523 Da

Resolves to

Protein

UniProtQ9RZ04UniProt nameQ9RZ04_DEIRA

Gene

NCBI Gene1798006

Pharmacology

KEGGdra:DR_A0149

Structure

PDB1WOGPDB1WOHPDB1WOI

Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action

2GO termsFunction, process and component, as structured annotations

1Pfam domainDomain architecture mapped to Pfam families and clans

1+ReferenceStructured and connected to the statements they support

Which compounds in development act on Agmatinase, putative, and which indications are they being tested in?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account